首页 >
法规速递
-
Page: Repaglinide product-specific bioequivalence guidance-2025/6/30
2025-07-01查看详情 > -
Page: EudraVigilance: electronic reporting-2025/7/31
2025-08-01查看详情 > -
国家药监局药审中心关于发布《中药注册受理审查指南（试行）》的通告（2025年第41号）-2025/9/19
2025-09-22查看详情 > -
Page: International Coalition of Medicines Regulatory Authorities (ICMRA)-2025/10/24
2025-10-27查看详情 > -
Page: List of medicines under additional monitoring-2025/11/26
2025-11-27查看详情 > -
2025年12月19日中药品种保护受理公示-2025/12/19
2025-12-22查看详情 > -
Document: Committee for Advanced Therapies (CAT): Work Plan 2026-2026/2/4
2026-02-05查看详情 > -
图解海报｜初识UDI-2026/3/13
2026-03-16查看详情 > -
关于公开征求《抗体偶联放射性核素药物药学研究与评价技术指导原则（征求意见稿）》意见的通知-2026/4/13
2026-04-14查看详情 > -
Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry(Final)-2023/01/23
2023-01-23查看详情 >
